Choose a Product

  • vallos® demineralized allograft granules

    Select Option

  • Geistlich Bio-Oss®

    1-20111

  • Gem21S®

    BUY

BIOBRIEF

Vertical and Horizontal Maxillary Ridge Reconstruction with Advanced Grafting

Nikolaos Soldatos, DDS, PhD, MSD

THE SITUATION

A 26-year-old edentulous female presented for implant-supported maxillary rehabilitation. She was systemically healthy and classified as ASA I. Clinical and radiographic evaluation revealed a Seibert Class III maxillary ridge defect with combined horizontal and vertical deficiencies. The patient exhibited a medium smile line and reported a highly active lifestyle with regular physical activity, indicating the need for a stable, durable, and esthetically driven implant rehabilitation capable of meeting long-term functional demands.

THE RISK PROFILE

Low RiskMedium RiskHigh Risk
Patient’s healthIntact immune system
Non-smoker
Light smokerImpaired immune system 
Patient’s esthetic requirementsLowMediumHigh
Height of the smile lineLowMediumHigh
Gingival biotypeThick – “low scalloped”Medium – “medium scalloped”Thin – “high scalloped”
Infection at implant sightNoneChronicAcute
Bone height at adjacent tooth≤ 5 mm from contact point5.5 – 6.5 mm from contact point≥ 7 mm from contact point
Soft-tissue anatomyIntactCompromised
Bone anatomy of the alveolar ridgeNo defectHorizontal defectVertical defect

THE APPROACH

Horizontal and vertical ridge augmentation was performed using a full-thickness maxillary flap with two distal vertical releasing incisions. Extensive buccal periosteal release and cortical perforations were carried out. A composite graft of large-particle vallos® allograft (demineralized cortical granules) and large-particle Geistlich Bio-Oss® xenograft, combined with rhPDGF-BB, a component of GEM 21S®, was placed and stabilized under a high-density PTFE membrane, which was secured with four horizontal mattress and multiple simple interrupted 4-0 PTFE sutures.

Pre‑operative occlusal photograph of the maxillary arch showing a pronounced Seibert Class III ridge deformity, with simultaneous horizontal and vertical soft and hard tissue loss in the edentulous area.
Intraoperative view following reflection of full‑thickness flaps, revealing a pronounced combined horizontal and vertical ridge deficiency.
Upper left view showing the mixture of large-particle vallos® allograft, demineralized cortical granules, and large-particle Geistlich Bio-Oss® xenograft, combined with rhPDGF-BB, a component of GEM 21S®.
Upper right view showing the mixture of large-particle vallos® allograft, demineralized cortical granules, and large-particle Geistlich Bio-Oss® xenograft, combined with rhPDGF-BB, a component of GEM21S®.
Closure of the maxilla was achieved using a PTFE barrier membrane and 4‑0 PTFE sutures. Horizontal mattress sutures were placed to provide initial tension relief and flap stabilization, while simple interrupted sutures were used for precise approximation of the wound margins.
Six‑month postoperative CBCT images with virtual implant planning reveal sites #5, 7, 10, and 12, exhibiting 5–7 mm of horizontal ridge augmentation and 3–4 mm of vertical ridge augmentation.
Intraoperative view demonstrating vertical and horizontal ridge augmentation at 7 months following the initial augmentation procedure.
A 4.3 × 8 mm tapered implant with crestal sinus elevation was placed at site #5, and a 4.3 × 10 mm tapered implant was placed at site #7.
(Left) A 4.3 × 10 mm implant was inserted at the site. (Right) Placement of a 4.3 × 10 mm implant in conjunction with a crestal sinus elevation.

“The patient’s young age and
excellent systemic health are favorable prognostic factors, but achieving optimal outcomes requires meticulous surgical execution, careful soft tissue management, and strict adherence to post-operative instructions to minimize complications and ensure long-term success.”

Nikolaos Soldatos, DDS, PhD, MSD

THE OUTCOME

Horizontal (5–7 mm) and vertical (3–4 mm) ridge augmentation were successfully obtained, with stablewound management achieved through precise suturing techniques. The osteoinductive properties of the large vallos®, demineralized granules combined with rhPDGF-BB, a component of GEM21S® promoted high-quality bone regeneration, whereas the large Geistlich Bio‑Oss®, xenograft particles contributed to volume preservation by moderating resorption. As a result, four 4.3 mm implants were placed with high primary stability, each exceeding 35 N·cm of insertion torque, providing a strong foundation for a predictable esthetic and functional restoration.

The combination of rhPDGF-BB, a component of GEM 21S®, promotes enhanced bone regeneration by stimulating cellular proliferation and osteogenesis. When supplemented with Geistlich Bio-Oss®, which maintains graft volume through slow resorption kinetics, this approach provides predictable ridge augmentation. Together, these graft components support stable, high‑quality bone formation and foster optimal conditions for long‑term implant integration.”

Nikolaos Soldatos, DDS, PhD, MSD

Nikolaos Soldatos, DDS, PhD, MSD

Dr. Soldatos is a tenure-track Associate Professor and Clinical Director of the Postgraduate Advanced Program in Periodontics at Oregon Health & Science University. He is a Board-Certified Periodontist and Implant Surgeon, he holds a DDS, PhD, and MSD, and has completed advanced periodontal and implant training in both the U.S. and Europe. Dr. Soldatos’ research focuses on translational implant biology and bone regeneration. He is also a Fellow of the Academy of Osseointegration.

  • vallos® demineralized allograft granules

    Select Option

  • Geistlich Bio-Oss®

    1-20111

  • Gem21S®

    BUY